![]() | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
| "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2019-05-13 Sale | 2019-05-15 4:06 pm | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 144,806 | $8.8898 | $1,287,296 | 198,141 (Indirect Direct) | View |
2019-05-17 Purchase | 2019-05-21 4:11 pm | Recro Pharma Inc. | REPH | Ajdler Arnaud Director | 40,000 | $9 | $360,000 | 1,104,546 (Indirect Direct) | View |
2020-04-17 Sale | 2020-04-20 4:32 pm | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 80,000 | $8.22 | $657,600 | 161,194 (Indirect Direct) | View |
2020-04-17 Sale(A) | 2020-04-20 7:42 pm | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 80,000 | $8.22 | $657,600 | 241,194 (Indirect Direct) | View |
2020-12-18 Sale | 2020-12-22 7:52 pm | Recro Pharma Inc. | REPH | SCP Vitalife Partners II LP 10% Owner | 18,587 | $3.0304 | $56,326 | 2,154,313 (Direct) | View |
2020-12-18 Sale | 2020-12-22 7:53 pm | Recro Pharma Inc. | REPH | SCP Vitalife Partners (Israel) II L.P. 10% Owner | 6,208 | $3.0304 | $18,813 | 719,847 (Direct) | View |
2020-12-22 Sale | 2020-12-28 8:18 pm | Recro Pharma Inc. | REPH | SCP Vitalife Partners II LP 10% Owner | 56,375 | $3.17 | $178,709 | 2,097,938 (Direct) | View |
2020-12-22 Sale | 2020-12-28 8:18 pm | Recro Pharma Inc. | REPH | SCP Vitalife Partners (Israel) II L.P. 10% Owner | 18,830 | $3.17 | $59,691 | 701,017 (Direct) | View |
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2019-05-09 Option Award | 2019-05-13 10:43 am | N/A N/A | Recro Pharma Inc. | REPH | Flynn Karen Director | 7,955 | $0 | 10,888 (Direct) | View |
2019-05-09 Option Award | 2019-05-13 10:43 am | N/A 2029-05-09 | Recro Pharma Inc. | REPH | Flynn Karen Director | 10,888 | $8.8 | 10,888 (Direct) | View |
2019-05-13 Exercise | 2019-05-15 4:06 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 123,500 | $2.47 | 198,141 (Direct) | View |
2019-05-13 Exercise | 2019-05-15 4:06 pm | N/A 2024-12-17 | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 123,500 | $2.47 | 198,141 (Direct) | View |
2019-06-05 Exercise | 2019-06-07 5:19 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 2,500 | $0 | 5,000 (Direct) | View |
2019-06-05 Tax Withholding | 2019-06-07 5:19 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 719 | $9.55 | 5,000 (Direct) | View |
2019-06-05 Exercise | 2019-06-07 5:19 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 2,500 | $0 | 5,000 (Direct) | View |
2019-11-21 Other | 2019-11-22 5:03 pm | N/A N/A | Baudax Bio Inc. | BXRX | Recro Pharma Inc. 10% Owner | 9,211,145 | $0 | 0 (Direct) | View |
2019-11-21 Other | 2019-11-22 5:03 pm | N/A N/A | Baudax Bio Inc. | BXRX | Recro Pharma Inc. 10% Owner | 9,211,245 | $0 | 0 (Direct) | View |
2019-12-05 Option Award | 2019-12-09 6:25 pm | N/A N/A | Recro Pharma Inc. | REPH | Ajdler Arnaud Director | 7,439 | $0 | 15,394 (Direct) | View |
2019-12-05 Option Award | 2019-12-09 6:27 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 93,550 | $0 | 246,691 (Direct) | View |
2019-12-05 Option Award | 2019-12-09 6:28 pm | N/A N/A | Recro Pharma Inc. | REPH | Weisman Wayne Director | 15,284 | $0 | 49,696 (Direct) | View |
2019-12-05 Option Award | 2019-12-09 6:29 pm | N/A N/A | Recro Pharma Inc. | REPH | Reasons Bryan M. Director | 9,156 | $0 | 32,143 (Direct) | View |
2019-12-05 Option Award | 2019-12-09 6:35 pm | N/A N/A | Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director | 15,284 | $0 | 42,696 (Direct) | View |
2019-12-05 Option Award | 2019-12-09 6:37 pm | N/A N/A | Recro Pharma Inc. | REPH | ALTOMARI ALFRED Director | 15,284 | $0 | 44,196 (Direct) | View |
2019-12-05 Option Award | 2019-12-09 6:38 pm | N/A N/A | Recro Pharma Inc. | REPH | Ashton William Director | 17,582 | $0 | 44,994 (Direct) | View |
2019-12-05 Option Award | 2019-12-09 6:42 pm | N/A N/A | Recro Pharma Inc. | REPH | Berelowitz Michael Director | 13,848 | $0 | 41,260 (Direct) | View |
2019-12-05 Option Award | 2019-12-09 6:43 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 17,283 | $0 | 48,812 (Direct) | View |
2019-12-05 Option Award | 2019-12-16 7:47 pm | N/A N/A | Recro Pharma Inc. | REPH | Flynn Karen Director | 11,071 | $0 | 39,283 (Direct) | View |
2020-01-02 Tax Withholding | 2020-01-03 4:51 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 4,945 | $17.53 | 241,746 (Direct) | View |
2020-01-02 Tax Withholding | 2020-01-03 4:59 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 979 | $17.53 | 47,833 (Direct) | View |
2020-01-18 Exercise | 2020-01-22 5:44 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 5,000 | $0 | 5,000 (Direct) | View |
2020-01-18 Tax Withholding | 2020-01-22 5:44 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 5,552 | $16.38 | 5,000 (Direct) | View |
2020-01-18 Exercise | 2020-01-22 5:44 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 5,000 | $0 | 5,000 (Direct) | View |
2020-01-18 Tax Withholding | 2020-01-22 5:45 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 1,095 | $16.38 | 46,738 (Direct) | View |
2020-02-03 Option Award | 2020-02-05 4:37 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 12,000 | $0 | 45,000 (Direct) | View |
2020-02-03 Option Award | 2020-02-05 4:37 pm | N/A 2030-02-03 | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 45,000 | $16.62 | 45,000 (Direct) | View |
2020-04-17 Exercise | 2020-04-20 7:42 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 80,000 | $2.47 | 241,194 (Direct) | View |
2020-04-17 Exercise | 2020-04-20 7:42 pm | N/A 2024-12-16 | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 80,000 | $2.47 | 241,194 (Direct) | View |
2020-05-07 Option Award | 2020-05-11 5:00 pm | N/A N/A | Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director | 8,363 | $0 | 12,405 (Direct) | View |
2020-05-07 Option Award | 2020-05-11 5:00 pm | N/A 2030-05-07 | Recro Pharma Inc. | REPH | CHURCHILL WINSTON J Director | 12,405 | $8.37 | 12,405 (Direct) | View |
2020-05-07 Option Award | 2020-05-11 5:03 pm | N/A N/A | Recro Pharma Inc. | REPH | Berelowitz Michael Director | 8,363 | $0 | 12,405 (Direct) | View |
2020-05-07 Option Award | 2020-05-11 5:03 pm | N/A 2030-05-07 | Recro Pharma Inc. | REPH | Berelowitz Michael Director | 12,405 | $8.37 | 12,405 (Direct) | View |
2020-05-07 Option Award | 2020-05-11 5:04 pm | N/A N/A | Recro Pharma Inc. | REPH | Ashton William Director | 8,363 | $0 | 12,405 (Direct) | View |
2020-05-07 Option Award | 2020-05-11 5:04 pm | N/A 2030-05-07 | Recro Pharma Inc. | REPH | Ashton William Director | 12,405 | $8.37 | 12,405 (Direct) | View |
2020-05-07 Option Award | 2020-05-11 5:05 pm | N/A N/A | Recro Pharma Inc. | REPH | Reasons Bryan M. Director | 8,363 | $0 | 12,405 (Direct) | View |
2020-05-07 Option Award | 2020-05-11 5:05 pm | N/A 2030-05-07 | Recro Pharma Inc. | REPH | Reasons Bryan M. Director | 12,405 | $8.37 | 12,405 (Direct) | View |
2020-05-07 Option Award | 2020-05-11 5:06 pm | N/A N/A | Recro Pharma Inc. | REPH | Weisman Wayne Director | 8,363 | $0 | 12,405 (Direct) | View |
2020-05-07 Option Award | 2020-05-11 5:06 pm | N/A 2030-05-07 | Recro Pharma Inc. | REPH | Weisman Wayne Director | 12,405 | $8.37 | 12,405 (Direct) | View |
2020-05-07 Option Award | 2020-05-11 5:07 pm | N/A N/A | Recro Pharma Inc. | REPH | Ajdler Arnaud Director | 8,363 | $0 | 12,405 (Direct) | View |
2020-05-07 Option Award | 2020-05-11 5:07 pm | N/A 2030-05-07 | Recro Pharma Inc. | REPH | Ajdler Arnaud Director | 12,405 | $8.37 | 12,405 (Direct) | View |
2020-06-05 Exercise | 2020-06-09 4:32 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 2,500 | $0 | 2,500 (Direct) | View |
2020-06-05 Tax Withholding | 2020-06-09 4:32 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 852 | $4.95 | 2,500 (Direct) | View |
2020-06-05 Exercise | 2020-06-09 4:32 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 2,500 | $0 | 2,500 (Direct) | View |
2020-12-05 Tax Withholding | 2020-12-09 5:43 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE CEO | 34,128 | $2.3 | 207,066 (Direct) | View |
2020-12-05 Tax Withholding | 2020-12-09 5:44 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 7,611 | $2.3 | 52,775 (Direct) | View |
2020-12-15 Option Award | 2020-12-18 8:55 pm | N/A N/A | Recro Pharma Inc. | REPH | ENLOE J DAVID JR CEO | 19,802 | $0 | 194,175 (Direct) | View |
2020-12-15 Option Award | 2020-12-18 8:55 pm | N/A N/A | Recro Pharma Inc. | REPH | ENLOE J DAVID JR CEO | 132,013 | $0 | 194,175 (Direct) | View |
2020-12-15 Option Award | 2020-12-18 8:55 pm | N/A 2030-12-15 | Recro Pharma Inc. | REPH | ENLOE J DAVID JR CEO | 194,175 | $3.03 | 194,175 (Direct) | View |
2020-12-15 Option Award | 2020-12-18 8:57 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 79,208 | $0 | 116,505 (Direct) | View |
2020-12-15 Option Award | 2020-12-18 8:57 pm | N/A 2030-12-15 | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 116,505 | $3.03 | 116,505 (Direct) | View |
2021-01-02 Tax Withholding | 2021-01-05 4:57 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 1,210 | $3.09 | 130,773 (Direct) | View |
2021-01-02 Tax Withholding | 2021-01-05 5:04 pm | N/A N/A | Recro Pharma Inc. | REPH | HENWOOD GERALDINE Director | 5,599 | $3.09 | 201,467 (Direct) | View |
2021-01-08 Option Award | 2021-01-12 5:18 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 36,000 | $0 | 384,163 (Direct) | View |
2021-01-08 Option Award | 2021-01-12 5:18 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 200,000 | $0 | 384,163 (Direct) | View |
2021-01-08 Option Award | 2021-01-12 5:18 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 30,000 | $0 | 384,163 (Direct) | View |
2021-01-08 Tax Withholding | 2021-01-12 5:18 pm | N/A N/A | Recro Pharma Inc. | REPH | Lake Ryan David CFO | 12,610 | $2.99 | 384,163 (Direct) | View |